HilleVax, Inc. (HLVX) Tops Q2 EPS by 6c Aug 6, 2025 06:01PM
XOMA Royalty to acquire HilleVax for $1.95 per share plus contingent rights Aug 4, 2025 07:00AM
HilleVax (HLVX) Halted, News Pending Aug 4, 2025 07:00AM
HilleVax, Inc. (HLVX) Reports Q1 Loss of $0.12 May 8, 2025 04:41PM
HilleVax (HLVX) to Cut 40% Staff Jul 31, 2024 04:00PM


Jul 9, 2024 06:06AM H.C. Wainwright Downgrades HilleVax, Inc. (HLVX) to Neutral
Jul 9, 2024 03:57AM Stifel Downgrades HilleVax, Inc. (HLVX) to Hold
Jul 8, 2024 12:06PM Guggenheim Downgrades HilleVax, Inc. (HLVX) to Neutral
Jul 8, 2024 10:03AM JPMorgan Downgrades HilleVax, Inc. (HLVX) to Overweight
Jul 8, 2024 08:04AM HilleVax (HLVX) shares sink as HIL-214 results disappoint
Jul 8, 2024 07:37AM HilleVax (HLVX) to Resume Trading at 8 a.m.
Jul 8, 2024 07:30AM HilleVax (HLVX) Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
Jul 8, 2024 07:29AM HilleVax (HLVX) Halted, News Pending